Rosacea affects roughly 3 to 5 percent of people worldwide, making it one of the more common chronic skin conditions, though far from the most visible in public awareness. Two large meta-analyses put the global prevalence at about 5.5 percent and 3.2 percent respectively, a spread that reflects how differently studies define and detect the condition across countries and populations.1PubMed. Incidence and prevalence of rosacea: a systematic review and meta-analysis2JAAD Reviews. Prevalence of rosacea: A systematic review and meta-analysis of population-based studies The honest picture of who gets rosacea is more varied than the stereotype of a fair-skinned person with rosy cheeks suggests, and many of the people living with it have never been diagnosed.
What the Prevalence Numbers Actually Mean
The two headline estimates come from systematic reviews that pooled data from population-based studies spanning multiple continents. One, published in the British Journal of Dermatology, calculated a prevalence of about 5.5 percent in the general population. The other, from JAAD Reviews, arrived at roughly 3.2 percent but noted the range across individual studies was enormous, from as low as 0.09 percent to over 15 percent.2JAAD Reviews. Prevalence of rosacea: A systematic review and meta-analysis of population-based studies That kind of variation tells you how much the number you get depends on where you look and how carefully you look. Studies using dermatologist examinations consistently find more cases than studies relying on medical records, because many people with mild rosacea never visit a doctor for it.
Among people who do see a dermatologist for skin complaints, roughly 2.4 percent turn out to have rosacea.1PubMed. Incidence and prevalence of rosacea: a systematic review and meta-analysis When broader diagnostic criteria are used and milder forms are included, some estimates push prevalence as high as 10 percent.3PubMed Central. The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea? Whether your personal doctor would call a mild flush “rosacea” or “sensitive skin” plays a surprisingly large role in the numbers.
Age and Sex Patterns
Rosacea is overwhelmingly a condition of middle adulthood. The meta-analysis in the British Journal of Dermatology found it most commonly affects people between 45 and 60.1PubMed. Incidence and prevalence of rosacea: a systematic review and meta-analysis That said, it can show up earlier. A retrospective study of 840 women with rosacea found the average age was about 36, and a similar study of 215 male patients put the average at roughly 39.4PubMed. Differences in clinical characteristics of rosacea across age groups: A retrospective study of 840 female patients5PubMed Central. Differences in the Clinical Characteristics of Male Patients With Different Ages of Rosacea: A Retrospective Study of 215 Male Outpatients Teenagers and people in their early twenties can develop rosacea, though it is much less common. If you are in your thirties and notice facial redness that was not there before, you are right in the zone.
Women are diagnosed more often, with a pooled prevalence of about 5.4 percent compared to about 3.9 percent in men.1PubMed. Incidence and prevalence of rosacea: a systematic review and meta-analysis That gap may partly reflect the reality that women tend to seek dermatological care more frequently. The sexes differ more in which form of rosacea they develop than in whether they develop it at all. The flushing and visible-blood-vessel type and the bumpy, pimple-like type appear at similar rates in men and women. But phymatous rosacea, the subtype that causes thickened, bulbous tissue (most famously on the nose), is dramatically more common in men, affecting roughly 29 percent of male patients compared to about 4 percent of female patients in a meta-analysis of subtype distribution.6JAMA Dermatology. Assessment of Frequency of Rosacea Subtypes in Patients With Rosacea: A Systematic Review and Meta-analysis
Skin Color, Ethnicity, and the Underdiagnosis Problem
The traditional textbook description of rosacea centers on fair-skinned people of Northern European or Celtic descent, and people with lighter Fitzpatrick skin phototypes do get diagnosed at higher rates.7PubMed Central. Dermatology: how to manage rosacea in skin of colour But the picture in darker skin tones is almost certainly distorted by underdiagnosis rather than true absence. Redness and dilated blood vessels, the two cardinal signs clinicians look for, are harder to see through darker pigment. That means people with more melanin may go undiagnosed or get diagnosed later, when the disease has already progressed.8PubMed. Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: Review and clinical practice experience
The numbers bear this out in ways that should make everyone cautious about the “white people’s disease” framing. A U.S. survey of over 31 million rosacea clinic visits found that only 2 percent of patients were Black, 2.3 percent were Asian or Pacific Islander, and about 4 percent were Hispanic or Latinx. But a study of Korean patients with rosacea found that around 40 percent of them had darker skin phototypes, and a Colombian study found 12 percent of rosacea patients had phototypes IV or V.7PubMed Central. Dermatology: how to manage rosacea in skin of colour These findings suggest that clinicians trained to associate rosacea with pale skin are simply missing it in other groups. If you have darker skin and experience burning, stinging, or swelling on your face without an obvious cause, rosacea deserves a place on the list of possibilities even if your doctor does not immediately think of it.
Genetics and Family History
If your parents or siblings have rosacea, your own odds go up. A retrospective study that traced family trees of 130 rosacea patients found that about half had at least one relative with the condition. When researchers extended their investigation across entire kindreds spanning up to six generations, they identified affected relatives in roughly 69 percent of families.9PubMed Central. Intrafamilial Transmission of Rosacea Spanning Six Generations: A Retrospective Observational Study That is a strong familial signal, higher than previous estimates of 30 to 50 percent that relied on patients reporting family history from memory alone.
The genetic architecture, though, looks complex. Whole-genome sequencing of multiple families with rosacea has identified rare variants in several different genes, but no single gene has been found that consistently drives the condition across unrelated families.10Nature Communications. Whole genome sequencing identifies genetic variants associated with neurogenic inflammation in rosacea Some of the implicated genes play roles in nerve signaling and inflammation, which fits with what researchers know about the disease, but the overall picture is one of high genetic heterogeneity. There is no single “rosacea gene” waiting to be discovered. Instead, many different genetic paths seem to lead to similar facial symptoms.
What Is Actually Happening in the Skin
Rosacea involves a cascade of innate immune overactivity and neurovascular dysfunction, though the precise sequence of events is still being worked out. One well-established piece of the puzzle is cathelicidin, an antimicrobial peptide that healthy skin uses to fight infection. In people with rosacea, facial skin produces abnormally high levels of cathelicidin, and the forms of the peptide are different from those found in unaffected skin. Those abnormal peptides are produced by overactive enzymes in the outer layer of skin and drive inflammation and blood vessel growth.11PubMed. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea Essentially, a defense system meant to protect you from microbes is misfiring and attacking your own tissue.
On the nerve side, receptors called TRPV1 and TRPA1, which detect temperature, spice, and other chemical irritants, are thought to contribute to the flushing and stinging that rosacea patients experience.12PubMed. Neurovascular aspects of skin neurogenic inflammation These receptors respond to heat, cold, capsaicin, and reactive oxygen species, which helps explain why so many of the classic rosacea triggers (hot drinks, sun exposure, spicy food, alcohol) converge on the same flushing response. The triggers are not causing the disease; they are activating an already oversensitive system.
Common Triggers and Dietary Patterns
If you have rosacea, you have probably noticed that certain things make your face flare. The most commonly reported culprits include alcohol, spicy food, hot drinks, and foods high in histamine like aged cheese, wine, and processed meats. Cinnamaldehyde-containing foods, a category that includes tomatoes, citrus fruits, and chocolate, are another frequent offender.13PubMed Central. Rosacea and Diet: What is New in 2021? These triggers do not cause rosacea, but they activate the neurovascular pathways already primed to overreact.
There is also an overlap with gastrointestinal health. Studies have found that rosacea patients tend to have a higher prevalence of gastrointestinal issues, and at least one study reported improvement in skin symptoms after treating small intestinal bacterial overgrowth.14PubMed Central. Diet and rosacea: the role of dietary change in the management of rosacea The gut-skin connection in rosacea is still poorly understood, but it is one reason some dermatologists ask about digestive symptoms when evaluating a patient with persistent facial inflammation.
When Rosacea Reaches the Eyes
One of the most underappreciated facts about rosacea is how often it involves the eyes. When researchers formally diagnose ocular rosacea in the general population, the prevalence sits around 10 percent of all rosacea patients. But when dermatologists actively examine the eyes of people who come in with skin rosacea, about 44 percent show some form of ocular involvement.15PubMed. Prevalence of ocular manifestations in cutaneous rosacea: systematic review and meta-analysis Some estimates push that figure even higher, with one review suggesting up to 72 percent of people with skin rosacea will develop eye symptoms at some point.16JEADV Clinical Practice. Ocular rosacea: The often‐overlooked component of rosacea
The typical eye symptoms include chronic dry eye, gritty or burning sensations, inflamed eyelids, and redness along the lash line. In some cases, ocular rosacea shows up before any skin changes, which can lead to years of misdiagnosis as generic dry eye or allergic conjunctivitis. If you have persistent eye irritation and any history of facial redness or flushing, mentioning both to your doctor increases the chance of getting the right diagnosis.
Links to Cardiovascular and Metabolic Health
A body of observational research has explored whether rosacea is associated with broader health risks beyond the skin. A meta-analysis pooling data across studies found no overall increase in cardiovascular disease events among rosacea patients, but it did find a modest association with several cardiovascular risk factors: higher rates of hypertension, abnormal cholesterol levels, and metabolic syndrome.17PubMed Central. Association between Rosacea and Cardiovascular Diseases and Related Risk Factors: A Systematic Review and Meta-Analysis No link to diabetes was found in that analysis.
A separate retrospective cohort study of women found that those with rosacea had roughly a 20 percent higher risk of developing cardiovascular disease and a 29 percent higher risk of coronary heart disease specifically, though stroke risk was not significantly elevated.18PubMed Central. Association of Rosacea With Cardiovascular Disease: A Retrospective Cohort Study A smaller case-control study also found significantly higher rates of insulin resistance and elevated cholesterol, blood pressure, and inflammatory markers in rosacea patients compared to matched controls.19PubMed. The relationship between rosacea and insulin resistance and metabolic syndrome
None of this means rosacea causes heart disease. The relationship likely reflects shared inflammatory pathways or common underlying metabolic tendencies. But it does mean that rosacea is not purely a cosmetic nuisance. If you are managing it, keeping an eye on standard cardiovascular risk factors like blood pressure and cholesterol is reasonable regardless.
The Emotional Toll
Rosacea sits squarely on the face, and the psychological burden of that visibility can be significant. Studies consistently find that people with rosacea report lower quality of life compared to people without skin disease, with one meta-analysis finding a large overall reduction in health-related quality of life scores.20PubMed Central. Health-related Quality of Life of Patients with Rosacea: A Systematic Review and Meta-analysis of Real-world Data Patients frequently describe low self-esteem, reduced social interactions, and avoidance of situations where their skin might be noticed.21PubMed Central. Burden of Disease: The Psychosocial Impact of Rosacea on a Patient’s Quality of Life
The risk of developing depression and anxiety is elevated, and the relationship can become circular: stress exacerbates rosacea symptoms, and worsening symptoms increase stress.22PubMed Central. Psychosocial aspects of rosacea with a focus on anxiety and depression The good news is that effective treatment of skin symptoms tends to improve emotional well-being as well, which gives clinicians another reason to take even mild rosacea seriously rather than dismissing it as purely cosmetic.
The Rhinophyma Myth
Perhaps no aspect of rosacea carries more cultural baggage than rhinophyma, the bulbous, thickened nose that represents the most advanced form of phymatous rosacea. For centuries, a swollen red nose has been shorthand for heavy drinking in art and literature. Researchers tracing rhinophyma through history have found depictions from ancient Maya culture through Renaissance painting to modern caricature, almost always associated with alcohol.23PubMed. Rhinophyma in literature and the arts The association is wrong. Rhinophyma is a progression of rosacea caused by chronic tissue overgrowth, and while alcohol can trigger flushing in someone who already has the condition, it does not cause the structural changes.
The persistence of this myth has real consequences. People with rhinophyma sometimes face social stigma and assumptions about their habits that have nothing to do with reality. And because phymatous rosacea disproportionately affects men, it reinforces a gendered misconception that men get rosacea from drinking while women get it from having “sensitive skin.” Both framings miss the point. Rosacea is a chronic inflammatory condition driven by immune dysregulation and neurovascular sensitivity, and no amount of clean living will prevent it in someone whose biology is predisposed.